YAP1 and bladder transitional cell carcinoma: Our group recently demonstrated that YAP1 regulates the generation and expansion of CSCs in urothelial carcinoma of bladder and lung adenocarcinoma and that pharmacological inhibition of YAP1, in combination with chemotherapies, suppresses cancer progression by attenuating cancer stemness features [20,21,22].